OrderlyMeds' Response to Eli Lilly's Cease-and-Desist Letter ...Middle East

PR Newswire - News
OrderlyMeds Response to Eli Lillys Cease-and-Desist Letter

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response. Prescribers and pharmacists have been taking care of their patients with customized, compounded...

    Read More Details
    Finally We wish PressBee provided you with enough information of ( OrderlyMeds' Response to Eli Lilly's Cease-and-Desist Letter )

    Also on site :

    Most viewed in News


    Latest News